Current Issue

View Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences

Featured Articles

Scheduling and Optimization of Biomanufacturing Activities in Multi-product Facilities with Disposable Technologies

Gloria Gadea-Lopez, Ph.D. is Director of Production and Business Systems at the Shire Lexington, John Maguireis the Associate Director of Manufacturing Systems at Shire’s Lexington and Megan Rabideau is a Manufacturing Systems Engineer at Shire’s Lexington

Bristol Myers Squibb adopts positive CHMP opinion for Opdivo plus Yervoy for patients with Microsatellite instability high or mismatch repair deficient metastatic colorectal cancer

Bristol Myers Squibb

Best Practices For Successful Filter Integrity Testing Using Water Intrusion Test (WIT) Method

Monica Cardona and Ian Johnson Pall Life Sciences

Coupling single-pass TFF before loading onto a chromatography sorbent

View All Featured Articles

Headline News

Ubamatamab produces high rate of durable responses in early study of advanced low grade serous ovarian cancer

AstraZeneca opens $1 billion global research centre in Cambridge Massachusetts that will lift its local workforce by more than 50 per cent

AstraZeneca finalises $2 billion stake in Summit Therapeutics to speed up ivonescimab combination research

Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

From Product Characterization to Clinical Reliable Specifications

Presented by André Mischo, Associate Director Science & Technology at Novartis
11th May 2022

Evolve Manufacturing Processes by Implementing Disruptive Technologies

Presented by Presented Yuyi Shen, Associate Director and Head of Development & Manufacturing at Bolt Biotherapeutics and John Cyganowski, Director of Manufacturing Sciences and Technologies Downstream Americas for MilliporeSigma
19th November 2018

Extractables and Leachables have been used interchangeablely for too long. Are we still confused?

Presented by Ken Wong, Deputy Director at Sanofi Pasteur and Don DeCou, Extractable and Leachable Technology Manager at West Pharmaceutical Services
25th March 2019

View All Past Webinars

Featured Companies

View All Companies

Featured Video

At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.

There’s no kit for the perfect biotech process. Until now.

View All Videos